Lyra regains Nasdaq minimum bid price compliance after 12-day streak above $1.00

Lyra Therapeutics, Inc.

Received notice from Nasdaq on June 13, 2025, confirming compliance with Listing Rule 5550(a)(2).
Common stock maintained minimum bid price of $1.00 for 12 consecutive business days (May 28 - June 12, 2025).
The matter is now closed; no further action required from Nasdaq on this issue.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.